Effect of Growth Hormone on Uterine Receptivity in Women With Repeated Implantation Failure in an Oocyte Donation Program: A Randomized Controlled Trial

被引:62
作者
Altmae, Signe [1 ,2 ]
Mendoza-Tesarik, Raquel [3 ]
Mendoza, Carmen [3 ]
Mendoza, Nicolas [3 ,4 ]
Cucinelli, Francesco [5 ]
Tesarik, Jan [3 ]
机构
[1] Univ Tartu, Competence Ctr Hlth Technol, EE-50410 Tartu, Estonia
[2] Univ Granada, Dept Biochem & Mol Biol, Fac Sci, Granada 18016, Spain
[3] MARGen Clin, Mol Assisted Reprod & Genet, Granada 18006, Spain
[4] Univ Granada, Dept Obstet & Gynecol, Granada 18016, Spain
[5] San Camillo Forlanini Hosp, Dept Maternal & Fetal Hlth, I-00152 Rome, Italy
关键词
endometrial receptivity; growth hormone; implantation failure; IVF; RIF;
D O I
10.1210/js.2017-00359
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objective: Administration of growth hormone (GH) during ovarian stimulation has been shown to improve success rates of in vitro fertilization. GH beneficial effect on oocyte quality is shown in several studies, but GH effect on uterine receptivity is not clear. To assess it, we studied whether GH administration can improve the chance of pregnancy and birth in women who experienced repeated implantation failure (RIF) using donated oocyte programs. Design and Study Population: A total of 105 infertile women were enrolled in the randomized controlled trial: 70 women were with a history of RIF with donated oocytes, and 35 infertile women underwent the first oocyte donation attempt. Women receiving donated oocytes were treated with progressively increasing doses of oral estradiol, followed by intravaginal progesterone after previous pituitary desensitization with gonadotropin-releasing hormone agonist. Thirty-five RIF patients were treated with GH (GH patients), whereas the rest of the 35 RIF patients (non-GH patients) and 35 first attempt patients (positive control group) were not. Results: RIF patients receiving GH showed significantly thicker endometrium and higher pregnancy and live birth rates as compared with RIF patients of non-GH study group, although these rates remained somewhat lower as compared with the non-RIF patients of the positive control group. No abnormality was detected in any of the babies born. Conclusion: Our data of improved implantation, pregnancy, and live birth rates among infertile RIF patients treated with GH indicate that GH improves uterine receptivity. Copyright (C) 2018 Endocrine Society.
引用
收藏
页码:96 / 105
页数:10
相关论文
共 37 条
[1]   Growth hormone and its receptor in human ovaries from fetuses and adults [J].
Abir, Ronit ;
Garor, Roni ;
Felz, Carmela ;
Nitke, Shmuel ;
Krissi, Haim ;
Fisch, Benjamin .
FERTILITY AND STERILITY, 2008, 90 :1333-1339
[2]   Disturbances in the LIF pathway in the endometrium among women with unexplained infertility [J].
Aghajanova, Lusine ;
Altmae, Signe ;
Bjuresten, Kerstin ;
Hovatta, Outi ;
Landgren, Britt-Marie ;
Stavreus-Evers, Anneli .
FERTILITY AND STERILITY, 2009, 91 (06) :2602-2610
[3]   Endometrial gene expression analysis at the time of embryo implantation in women with unexplained infertility [J].
Altmae, S. ;
Martinez-Conejero, J. A. ;
Salumets, A. ;
Simon, C. ;
Horcajadas, J. A. ;
Stavreus-Evers, A. .
MOLECULAR HUMAN REPRODUCTION, 2010, 16 (03) :178-187
[4]   Endometrial transcriptome analysis indicates superiority of natural over artificial cycles in recurrent implantation failure patients undergoing frozen embryo transfer [J].
Altmae, Signe ;
Tamm-Rosenstein, Karin ;
Esteban, Francisco J. ;
Simm, Jaak ;
Kolberg, Liis ;
Peterson, Hedi ;
Metsis, Madis ;
Haldre, Kai ;
Horcajadas, Jose A. ;
Salumets, Andres ;
Stavreus-Evers, Anneli .
REPRODUCTIVE BIOMEDICINE ONLINE, 2016, 32 (06) :597-613
[5]   Research Resource: Interactome of Human Embryo Implantation: Identification of Gene Expression Pathways, Regulation, and Integrated Regulatory Networks [J].
Altmae, Signe ;
Reimand, Jueri ;
Hovatta, Outi ;
Zhang, Pu ;
Kere, Juha ;
Laisk, Triin ;
Saare, Merli ;
Peters, Maire ;
Vilo, Jaak ;
Stavreus-Evers, Anneli ;
Salumets, Andres .
MOLECULAR ENDOCRINOLOGY, 2012, 26 (01) :203-217
[6]  
[Anonymous], 1991, ANN NY ACAD SCI
[7]   Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial [J].
Bassiouny, Yasmin Ahmed ;
Dakhly, Dina Mohamed Refaat ;
Bayoumi, Yomna Ali ;
Hashish, Nawara Mohamed .
FERTILITY AND STERILITY, 2016, 105 (03) :697-702
[8]   Noonan syndrome: Genetics and responsiveness to growth hormone therapy [J].
Binder, Gerhard ;
Wittekindt, Nicola ;
Ranke, Michael B. .
HORMONE RESEARCH, 2007, 67 :45-49
[9]   GROWTH-HORMONE (GH)-BINDING PROTEIN-REGULATION BY ESTROGEN, PROGESTERONE, AND GONADOTROPINS IN HUMAN - THE EFFECT OF OVULATION INDUCTION WITH MENOPAUSAL GONADOTROPINS, GH, AND GESTATION [J].
BLUMENFELD, Z ;
BARKEY, RJ ;
YOUDIM, MBH ;
BRANDES, JM ;
AMIT, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (05) :1242-1249
[10]  
Blumenfeld Z, 1996, J PEDIATR ENDOCR MET, V9, P145